DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Tetrahydrouridine is an investigational drug.
There have been 17 clinical trials for Tetrahydrouridine. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2009.
The most common disease conditions in clinical trials are Lung Neoplasms, Head and Neck Neoplasms, and Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), EpiDestiny, Inc., and Yogen Saunthararajah.
Recent Clinical Trials for Tetrahydrouridine
|Effect of Food on the Pharmacokinetics of Decitabine/Tetrahydrouridine Combination Capsules in Healthy Adult Subjects||EpiDestiny, Inc.||Phase 1|
|A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease||National Institutes of Health (NIH)||Phase 1|
|A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease||EpiDestiny, Inc.||Phase 1|